# Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor

> **NCT02311088** · PHASE2 · TERMINATED · sponsor: **Uppsala University** · enrollment: 26 (actual)

## Conditions studied

- Dyspnea

## Interventions

- **DRUG:** Caffeine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02311088
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Too low enrolment rate
- **Last updated:** 2016-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311088, "Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02311088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*